Positions

Overview

  • Dr. Erdmann completed his MD/PhD at the University of Nebraska Medical Center. His research focused on understanding the mechanisms of HIV-mediated inflammation and neurotoxicity. He then joined the ABIM Research Pathway at UAB, completing his internship and residency before joining the Division of Infectious Disease as a fellow. He is now an Instructor of Medicine, and his research focuses on T cell responses in HIV under the mentorship of Dr. Paul Goepfert. Dr. Erdmann has described the role of CD4 T cells in controlling HIV infection through cytolytic activities.

    • Principal Investigator On

    Investigator On

  • A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults  awarded by Emory University
  • A-Z Clinical Trials Unit  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • A-Z Clinical Trials Unit  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Alabama Clinical Trials Unit (CTU)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • CoVPN 3006 Protocol Funding (PF) - Birmingham Clinical Research Site  awarded by Hutchinson (Fred) Cancer Research Center
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS
  • Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia  awarded by Duke University
  • Establishing Normative Cognitive Data for UAB Medical Professionals  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION
  • HIV Vaccine Trials Network Correlates Protocol Funding  awarded by Hutchinson (Fred) Cancer Research Center
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Deceased Donor Kidney Transplantation  awarded by Johns Hopkins University
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation  awarded by Johns Hopkins University
  • HPX3002/HVTN 706 Protocol Funding (PF)  awarded by Hutchinson (Fred) Cancer Research Center
  • HVTN Protocol Funding Year 14  awarded by Hutchinson (Fred) Cancer Research Center
  • Hope in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation  awarded by Johns Hopkins University
  • Identification of Drugs that Induce Terminal Transcriptional Silencing of Latent HIV-1 Infection  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Immunologic Health in Aging PLWH  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Impact of CCR5 Blockade in HIV+Kidney Transplant Recipients  awarded by University of California, San Francisco
  • Kidney Transplantation in Recipients and Donors with HIV: Long Term Follow up Study  awarded by Johns Hopkins University
  • Post Acute Sequelae of SARS-COV-2 Infection Initiative  awarded by NEW YORK UNIVERSITY SCHOOL OF MEDICINE
  • Private Grant  awarded by SCYNEXIS
  • Private Grant  awarded by MAYNE PHARMA INC
  • Private Grant  awarded by SUMMIT OXFORD LIMITED
  • Private Grant  awarded by AMPLYX PHARMACEUTICALS INC
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW
  • Private Grant  awarded by CONTRAFECT CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by TAKEDA PHARMACEUTICALS COMPANY LTD
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW
  • Private Grant  awarded by LEIDOS BIOMEDICAL RESEARCH, INC.
  • Program on Cellular Metabolism and Lung Fibrosis  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Prospective Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients  awarded by Johns Hopkins University
  • Researching Covid to Enhance Recovery (RECOVER) Initiative  awarded by New York University
  • The Natural History of Antifungal Failure in Invasive Candidiasis in the United States  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON)
  • UAB Center for AIDS Research (CFAR)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research - Core H - Basic Research Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS

    • Education And Training

  • Doctor of Medicine, University of Nebraska System : Omaha 2010
  • Doctor of Philosophy in Neuroscience, University of Nebraska System : Omaha 2008

    • Full Name

  • Nathan Erdmann